| Literature DB >> 27127658 |
Holly Stefen1, Chanchanok Chaichim1, John Power2, Thomas Fath3.
Abstract
Disruption of synaptic function at excitatory synapses is one of the earliest pathological changes seen in wide range of neurological diseases. The proper control of the segregation of neurotransmitter receptors at these synapses is directly correlated with the intact regulation of the postsynaptic cytoskeleton. In this review, we are discussing key factors that regulate the structure and dynamics of the actin cytoskeleton, the major cytoskeletal building block that supports the postsynaptic compartment. Special attention is given to the complex interplay of actin-associated proteins that are found in the synaptic specialization. We then discuss our current understanding of how disruption of these cytoskeletal elements may contribute to the pathological events observed in the nervous system under disease conditions with a particular focus on Alzheimer's disease pathology.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27127658 PMCID: PMC4835652 DOI: 10.1155/2016/2371970
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Figure 1Schematic representation of the cytoskeleton-dependent trafficking of neurotransmitter receptors. Depicted are the key structures of the synapse and associated cytoskeletal molecules. Numbers indicate the following steps: (1) Myosin V traffics vesicles with receptors from the soma to the distal dendritic sites via microtubules (MT) [116]. MT plus ends are indicated by green circles. (2) Once within spines, myosin V transports receptors to plasma membrane via actin filaments [117]. (3) Anchoring of receptors in the PSD relies on myosin II contractile force on actin cytoskeleton in combination with constant actin treadmilling/turnover [48]. Lateral diffusion of receptors to and from the PSD to presynaptic regions can occur. (4) Receptor internalization involves myosin VI activity. Myosin VI transports internalized receptors to endosomal organelles, facilitating recycling of receptors back to the membrane or to degradation pathways [95]. (5) Receptors can also travel between the PSD and peripheral sites [118, 119].
Figure 2Amyloid-β disrupts the actin cytoskeleton and receptor trafficking through multiple pathways. There are many conflicting pathways through which Aβ is proposed to alter the actin cytoskeleton. These may involve both up- and downregulation of cofilin activity. Activation of RhoA by Aβ [204] antagonistically inhibits Rac1 [206], both leading to increased cofilin activity. In contrast, Aβ can cause decrease in cofilin activity via activation of Cdc42 [211]. Both active and inactive cofilin are thought to be required for the formation of cofilin rods, which lead to impairment of intracellular transport [215]. Alternatively or in addition to this, altered expression and/or processing of actin filament stabilizing proteins [217, 218] may impact the trafficking of neurotransmitter receptors.